|
|||||
|
|
Clinical Trial of Safety and Efficacy of IHN-A21 for the Prevention of Nosocomial Staphylococcal Bloodstream Infection in Premature Infants |
|
| Authors: | Mitchell DeJonge David Burchfield Barry Bloom Maria Duenas Whit Walker Mark Polak Elizabeth Jung Dietra Millard Robert Schelonka Fabien Eyal Amy Morris Barry Kapik Destrey Roberson Karen Kesler Joe Patti Seth Hetherington |
| Affiliation: | a DeVos Children’s Hospital, Grand Rapids, Michigan b Shand’s Children’s Hospital, University of Florida, Gainesville, Florida c Wesley Medical Center, Wichita, Kansas d St. John Hospital and Medical Center, Detroit, Michigan e Greenville Memorial Hospital, Greenville, South Carolina f West Virginia University Hospital, Morgantown, West Virginia g St. John’s Mercy Medical Center, St. Louis, Missouri h Evanston Hospital, Evanston, Illinois i University of Alabama at Birmingham Hospital, Birmingham, Alabama j University of South Alabama Children’s & Women’s Hospital, Mobile, Alabama k Inhibitex, Inc., Alpharetta, Georgia l Rho, Inc., Chapel Hill, North Carolina. |
| Abstract: | |
| Keywords: | BSI, Bloodstream infection CoNS, Coagulase-negative staphylococci IGIV, Intravenous immune globulin LIS, Late-onset sepsis NEC, Necrotizing enterocolitis SAEs, Serious adverse events VLBW, Very low birth weight |
| 本文献已被 ScienceDirect 等数据库收录！ | |